The GLP-1 ad wars “Healthy Skepticism” comes weeks after Eli Lilly competitor and Ozempic-maker Novo Nordisk launched a print ...

Khloé’s decade-old comments about her weight are far more progressive than what she’s said in recent years, and it’s pretty ...

British content creator Elizabeth Read has lost more than 40 pounds on the weight loss injection, which is a drug that lowers ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

Scott Disick was seemingly surprised to learn that his Mounjaro weight-loss medications made a cameo on 'The Kardashians.' Khloe Kardashian advises to her sister's ex to "hide your drugs." ...

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...

Philippa Davis, 56, from East Sussex, has gone from a size 18 to a size 8 in just 15 months after being prescribed weight ...

The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion by 2031. Hype ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

Obesity strategy should not be built around a single drug Tirzepatide (Mounjaro) has had a remarkable journey to prominence since its UK marketing authorisation in 2023.1 Approved for glycaemic ...

Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit by the U.S. Department of Health and Human Services Office of Inspector ...

This Chicago lawyer's success with Ozempic shows how weight-loss drugs could unlock Americans' purchasing power — and ...